TBL1X and diabetic kidney disease: Altering DNA methylation, even via dietary interventions [84,104], may prove a novel therapeutic opportunity for DKD [105], with this analysis identifying targets for future study (TERT, VAX2, C12orf43, TBL1X, TNKS, BCL7B, ZEB2 and AKT1).